B. Bui

2.7k total citations
63 papers, 2.0k citations indexed

About

B. Bui is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, B. Bui has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 22 papers in Gastroenterology. Recurrent topics in B. Bui's work include Sarcoma Diagnosis and Treatment (44 papers), Gastrointestinal Tumor Research and Treatment (22 papers) and Vascular Tumors and Angiosarcomas (14 papers). B. Bui is often cited by papers focused on Sarcoma Diagnosis and Treatment (44 papers), Gastrointestinal Tumor Research and Treatment (22 papers) and Vascular Tumors and Angiosarcomas (14 papers). B. Bui collaborates with scholars based in France, United States and Germany. B. Bui's co-authors include Jean‐Yves Blay, Axel Le Cesne, Antoîne Italiano, Nicolas Penel, Florence Duffaud, Christine Chevreau, Isabelle Ray‐Coquard, Jean‐Michel Coindre, Didier Cupissol and David Pérol and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

B. Bui

62 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Bui France 24 1.5k 826 580 451 372 63 2.0k
Elena Palassini Italy 26 1.7k 1.1× 719 0.9× 1.2k 2.0× 284 0.6× 320 0.9× 65 2.1k
N.B. Bui France 11 1.5k 1.0× 984 1.2× 573 1.0× 372 0.8× 544 1.5× 23 1.8k
Bernd Kasper Germany 26 1.8k 1.2× 1.1k 1.3× 858 1.5× 314 0.7× 471 1.3× 171 2.5k
Agnès Neuville France 27 1.2k 0.8× 704 0.9× 471 0.8× 307 0.7× 309 0.8× 56 2.0k
Binh Bui Nguyen France 12 1.1k 0.7× 658 0.8× 275 0.5× 208 0.5× 410 1.1× 49 1.3k
Marc David Canada 17 1.5k 1.0× 809 1.0× 417 0.7× 337 0.7× 449 1.2× 49 1.9k
Charles Forscher United States 22 1.2k 0.8× 694 0.8× 372 0.6× 254 0.6× 402 1.1× 36 1.7k
Javier Martínez‐Trufero Spain 20 1.1k 0.8× 976 1.2× 168 0.3× 533 1.2× 204 0.5× 124 2.0k
Myles Smith United Kingdom 22 872 0.6× 892 1.1× 326 0.6× 528 1.2× 289 0.8× 79 1.8k
M. Ouali France 19 1.4k 1.0× 957 1.2× 350 0.6× 291 0.6× 454 1.2× 46 1.8k

Countries citing papers authored by B. Bui

Since Specialization
Citations

This map shows the geographic impact of B. Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Bui more than expected).

Fields of papers citing papers by B. Bui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Bui. The network helps show where B. Bui may publish in the future.

Co-authorship network of co-authors of B. Bui

This figure shows the co-authorship network connecting the top 25 collaborators of B. Bui. A scholar is included among the top collaborators of B. Bui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Bui. B. Bui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joensuu, Heikki, Jean‐Yves Blay, Alessandro Comandone, et al.. (2014). Phase 2 Trial to Evaluate the Efficacy and Safety of Dovitinib in Patients (Pts) with Gastrointestinal Stromal Tumor (Gist) Refractory and/or Intolerant to Imatinib (Im). Annals of Oncology. 25. v1–v1. 2 indexed citations
2.
Italiano, Antoîne, Esma Saâda, Angela Cioffi, et al.. (2012). Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications. Targeted Oncology. 8(4). 295–300. 9 indexed citations
3.
Garbay, Delphine, Axel Le Cesne, Nicolas Penel, et al.. (2011). Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Annals of Oncology. 23(1). 182–186. 126 indexed citations
4.
Dejean, C., Paul Sargos, J. Caron, et al.. (2011). Expérience de l’institut Bergonié à propos de 14 cas de tomothérapie hélicoïdale de tumeurs axiales et para-axiales. Cancer/Radiothérapie. 15(5). 404–412. 3 indexed citations
5.
Italiano, Antoîne, Maud Toulmonde, Angela Cioffi, et al.. (2011). Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival. Annals of Oncology. 23(6). 1601–1607. 111 indexed citations
6.
Dufresne, Armelle, François Bertucci, Nicolas Penel, et al.. (2010). Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. British Journal of Cancer. 103(4). 482–485. 27 indexed citations
7.
Italiano, Antoîne, Maud Toulmonde, Eberhard Stoeckle, et al.. (2010). Clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin. Annals of Oncology. 21(9). 1915–1921. 45 indexed citations
8.
Penel, Nicolas, Axel Le Cesne, B. Bui, et al.. (2010). Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Annals of Oncology. 22(2). 452–457. 169 indexed citations
9.
Cassier, Philippe A., Aurore Blesius, David Pérol, et al.. (2009). Neoadjuvant imatinib in patients with locally advanced GIST in the prospective BFR14 trial. Journal of Clinical Oncology. 27(15_suppl). 10551–10551. 6 indexed citations
10.
Duffaud, Florence, Isabelle Ray‐Coquard, B. Bui, et al.. (2009). Time to secondary resistance (TSR) after interruption of imatinib: Updated results of the prospective French Sarcoma Group randomized phase III trial on long-term survival. Journal of Clinical Oncology. 27(15_suppl). 10508–10508. 6 indexed citations
11.
Italiano, Antoîne, Nicolas Penel, Y Robin, et al.. (2008). Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. Annals of Oncology. 20(3). 425–430. 108 indexed citations
12.
Bui, B., Eberhard Stoeckle, Michèle Kind, & J.M. Coindre. (2007). Tumeurs stromales du tube digestif (GIST). ONCOLOGIE. 9(2). 144–151. 1 indexed citations
13.
Stoeckle, E., G. Kantor, F. Bonichon, et al.. (2006). Prospective evaluation of quality of surgery in soft tissue sarcoma. European Journal of Surgical Oncology. 32(10). 1242–1248. 62 indexed citations
14.
Kantor, G., et al.. (2006). Approche conservatrice et fonctionnelle dans les sarcomes des tissus mous des membres : place de la radiothérapie. Cancer/Radiothérapie. 10(6-7). 410–415. 6 indexed citations
15.
Thomas, L., B. Bui, Christine Chevreau, et al.. (2004). Prise en charge des sarcomes des tissus mous en première rechute locale isolée : étude rétrospective de 83 cas. Cancer/Radiothérapie. 8(5). 279–287. 5 indexed citations
16.
Lara, C. Tunon de, Gaëtan MacGrogan, E Bussières, et al.. (2004). Sarcomes primitifs du sein. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 33(7). 589–599. 5 indexed citations
17.
Musat, E., G. Kantor, J. Caron, et al.. (2004). Étude théorique d'une radiothérapie postopératoire avec modulation d'intensité d'un sarcome rétropéritonéal. Cancer/Radiothérapie. 8(4). 255–261. 22 indexed citations
18.
19.
Bui, B., B Chevallier, Christine Chevreau, et al.. (1995). Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.. Journal of Clinical Oncology. 13(10). 2629–2636. 57 indexed citations
20.
Stöckle, E, et al.. (1995). 847 Conservative local treatment by multimodality therapy in 361 adults’ soft tissue sarcoma (STS). European Journal of Cancer. 31. S177–S177. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Palassini Breakdown of academic impact, for papers by N.B. Bui Breakdown of academic impact, for papers by Bernd Kasper Breakdown of academic impact, for papers by Agnès Neuville Breakdown of academic impact, for papers by Binh Bui Nguyen Breakdown of academic impact, for papers by Marc David Breakdown of academic impact, for papers by Charles Forscher Breakdown of academic impact, for papers by Javier Martínez‐Trufero Breakdown of academic impact, for papers by Myles Smith Breakdown of academic impact, for papers by M. Ouali
Rankless by CCL
2026